SANNA, MONICA
SANNA, MONICA
100019 - Dipartimento di chimica e chimica industriale
Analogs, formulations and derivatives of imatinib: A patent review
2015-01-01 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica
Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors
2017-01-01 Musumeci, Francesca; Sanna, Monica; Greco, Chiara; Giacchello, Ilaria; Fallacara, Anna Lucia; Amato, Rosario; Schenone, Silvia
Pyrrolo[2,3-d]pyrimidines as kinase inhibitors
2017-01-01 Musumeci, Francesca; Sanna, Monica; Grossi, Giancarlo; Brullo, Chiara; Fallacara, Anna Lucia; Schenone, Silvia
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists.
2017-01-01 Giacchello, I.; Musumeci, F.; Greco, C.; Sanna, M.; Schenone, S.; Trincavelli, M. L.; Tuccinardi, T.
Synthesis of a new generation of pyrazolo[3,4-d]pyrimidine as SGK-1 inhibitors.
2017-01-01 Greco, C.; Sanna, M.; Musumeci, F.; Giacchello, I.; Perrotti, N.; Alcaro, S.; Ortuso, F.; Schenone, S.
Synthesis of a new generation of pyrazolo[3,4-d]pyrimidines as Fyn inhibitors
2017-01-01 Sanna, M.; Greco, C.; Musumeci, F.; Giacchello, I.; Schenone, S.; Fallacara, A. L.; Trist, I. M.; Botta, M.
Synthesis of heterocyclic compounds to be tested as potentiators or correctors of mutant CFTR in cystic fibrosis
2016-01-01 Musumeci, F.; Sanna, M.; Giacchello, I.; Mazzei, M.; Schenone, S.
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives active in a preclinical glioblastoma model.
2015-01-01 Musumeci, F.; Sanna, M.; Desogus, A.; Brullo, C.; Tintori, C.; Botta, M.; Indovina, P.; Giordano, A.; Schenone, S.
Water Solubility Enhancement of Pyrazolo[3,4-d]pyrimidine Derivatives via Miniaturized Polymer–Drug Microarrays
2018-01-01 Sanna, Monica; Sicilia, Giovanna; Alazzo, Ali; Singh, Nishant; Musumeci, Francesca; Schenone, Silvia; Spriggs, Keith A.; Burley, Jonathan C.; Garnett, Martin C.; Taresco, Vincenzo; Alexander, Cameron
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Analogs, formulations and derivatives of imatinib: A patent review | 1-gen-2015 | Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica | |
| Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors | 1-gen-2017 | Musumeci, Francesca; Sanna, Monica; Greco, Chiara; Giacchello, Ilaria; Fallacara, Anna Lucia; Amato, Rosario; Schenone, Silvia | |
| Pyrrolo[2,3-d]pyrimidines as kinase inhibitors | 1-gen-2017 | Musumeci, Francesca; Sanna, Monica; Grossi, Giancarlo; Brullo, Chiara; Fallacara, Anna Lucia; Schenone, Silvia | |
| Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists. | 1-gen-2017 | Giacchello, I.; Musumeci, F.; Greco, C.; Sanna, M.; Schenone, S.; Trincavelli, M. L.; Tuccinardi, T. | |
| Synthesis of a new generation of pyrazolo[3,4-d]pyrimidine as SGK-1 inhibitors. | 1-gen-2017 | Greco, C.; Sanna, M.; Musumeci, F.; Giacchello, I.; Perrotti, N.; Alcaro, S.; Ortuso, F.; Schenone, S. | |
| Synthesis of a new generation of pyrazolo[3,4-d]pyrimidines as Fyn inhibitors | 1-gen-2017 | Sanna, M.; Greco, C.; Musumeci, F.; Giacchello, I.; Schenone, S.; Fallacara, A. L.; Trist, I. M.; Botta, M. | |
| Synthesis of heterocyclic compounds to be tested as potentiators or correctors of mutant CFTR in cystic fibrosis | 1-gen-2016 | Musumeci, F.; Sanna, M.; Giacchello, I.; Mazzei, M.; Schenone, S. | |
| Synthesis of pyrazolo[3,4-d]pyrimidine derivatives active in a preclinical glioblastoma model. | 1-gen-2015 | Musumeci, F.; Sanna, M.; Desogus, A.; Brullo, C.; Tintori, C.; Botta, M.; Indovina, P.; Giordano, A.; Schenone, S. | |
| Water Solubility Enhancement of Pyrazolo[3,4-d]pyrimidine Derivatives via Miniaturized Polymer–Drug Microarrays | 1-gen-2018 | Sanna, Monica; Sicilia, Giovanna; Alazzo, Ali; Singh, Nishant; Musumeci, Francesca; Schenone, Silvia; Spriggs, Keith A.; Burley, Jonathan C.; Garnett, Martin C.; Taresco, Vincenzo; Alexander, Cameron |